Live
- Calcutta HC frees man arrested on charges of criticising Bengal minister on social media
- DC BM Santhosh reviews on Banking sector with the Bankers
- Stop the Labour 'supermajority', UK PM Sunak appeals to voters
- MLA Bandla Krisnamohan Reddy Inaugurates several development works in Gattu mandal
- Cyber security Awareness Rally helds in Ieeja
- DDRF team prepared on behalf of district police department to deal with disaster situations: SP Rohit Raju IPS
- ‘Operation Raavan’set for theatrical release on August 2
- Bhadrachalam MLA urges to merge five Panchayats in revenue devision
- 46 pc Indian IT professionals say all corporate data stored in Cloud is sensitive: Report
- Yoga and Nutrition for PCOS: A Holistic Approach to Natural Wellness
Scientist finds non-invasive method of cancer detection
Scientist finds non-invasive method of cancer detection
During the study, it was shown that circulating cell free DNA could be used as an effective marker to evaluate tumour burden in the patients, both in untreated and treated individuals. It also shows that during concurrent chemo-radiotherapy, ccfDNA load disappeared and after six months of follow up, appeared back due to distant metastasis.
Dr Samrendra Kumar Singh, assistant professor, School of Biotechnology in the Institute of Science, Banaras Hindu University (BHU), has found a non-invasive method to diagnose cervical cancer in patients.
His findings have been published in the 'Journal of Cancer Research and Therapeutics (JCRT)'. The study finds a cost-effective and specific method for early detection, treatment monitoring, the status of residual disease and distant tumour metastasis in cervical cancer patients. The study was undertaken in collaboration with the department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU.
He said that the sensitivity and specificity of this method and short half-life of ccfDNA makes this method reliable and potent as an affordable and real-time biomarker for detecting tumour burden in cervical carcinoma patients. The study has also shown a way to follow up prognostic outcomes of medication/surgery by using blood samples from cancer patients.
